Healthcare -
Biotechnology - NASDAQ - US
$ 15.04
-3.16 %
$ 1.19 B
Market Cap
-3.48
P/E
VRDN - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative VRDN - Viridian Therapeutics, Inc.
95 M
LAST VALUE
91.87%
2 YEAR CAGR
53.77%
5 YEAR CAGR
45.94%
10 YEAR CAGR